Miconazolnitraat Sanias (Miconazole Nitrate)

Miconazole nitrate blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By preventing ergosterol formation, the drug disrupts the fungal cell membrane, increasing permeability and leading to cell death, which clears the infection at the site of application.

The dosage and frequency are determined by the prescribing healthcare professional based on the infection type, severity, patient age and the specific product formulation. Patients should follow the prescriber’s instructions and the product label for proper application.

The safety of topical miconazole nitrate in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning pregnancy, or nursing should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Miconazolnitraat Sanias uses miconazole nitrate, an imidazole class antifungal, which is effective against a broad range of dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, imidazoles often have a broader spectrum but may be associated with more local irritation. Choice depends on infection type, patient tolerance and clinician preference.

Store the product at temperatures below 25 °C, in its original packaging, protected from moisture, heat and direct sunlight. Do not freeze. Proper storage helps maintain the stability and efficacy of the topical formulation.

The product is applied topically to the affected skin area. Clean and dry the area before use, then spread a thin layer of the cream or ointment as directed by the prescriber, usually twice daily or as indicated on the label. Wash hands after application unless treating the hands.

Serious risks include severe allergic reactions such as anaphylaxis, extensive contact dermatitis, swelling of the face or lips, and worsening of the infection despite treatment. If any of these occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to miconazole nitrate or any other component of the formulation should avoid using the product. It should also not be applied to broken skin, eyes, or mucous membranes, and patients with severe liver disease should consult a physician before use.